Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 0.32 USD -5.41% Market Closed
Market Cap: 45.3m USD

Wall Street
Price Targets

APLT Price Targets Summary
Applied Therapeutics Inc

There are no price targets for APLT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Applied Therapeutics Inc Competitors:
Price Targets
NTRA
Natera Inc
26% Upside
BCYC
Bicycle Therapeutics PLC
265% Upside
RNA
Avidity Biosciences Inc
134% Upside
NBIX
Neurocrine Biosciences Inc
24% Upside
4893
Noile-Immune Biotech Inc
162% Upside
301207
Hualan Biological Bacterin Inc
16% Upside
BRNS
Barinthus Biotherapeutics PLC
398% Upside
BBIO
BridgeBio Pharma Inc
40% Upside

Revenue
Forecast

Revenue Estimate
Applied Therapeutics Inc

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 3 years is 445%.

N/A
Past Growth
445%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Applied Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Applied Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APLT's stock price target?
Not Available

APLT doesn't have any price targets made by Wall Street professionals.

What is Applied Therapeutics Inc's Revenue forecast?
Projected CAGR
445%

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 3 years is 445%.

Back to Top